Symposia

Overview of Symposia

S - Symposia

S-1  Where do we end? How imbalances in sensory-processing and self disorders may disrupt world-self boundaries in psychosis

Chair: S. Damiani, University Pavia, Italy
Co-Chair: A. Estrade, University Pavia, Italy

Self-disorders: phenomenology and role in the formation of prodromes and 
psychotic symptoms
Andres Estrade 
Istitute of Psychology and Neuroscience, King's College, London
Self-other discrimination: source monitoring and false perceptions within the framework of self disturbances in psychopathology;Lukasz Gaweda
Polish Academy of Sciences PAN, Institute of Psychology, Warsaw
Self-other interactions: the characterization of social cognition deficits during
the early stages of psychosis;
Ana Catalan
LMU Munich
World-self boundaries: the relationship between self and perception in psychosis. Tools to measure it (eg. peri-personal space, world-self ambivalence) and 
the impact of perceptual processing
Stefano Damiani
University of Pavia, Dept., of Brain & Behavioral Sciences,

 

S-2  Exploring frontostriatal circuits and potential biomarkers for reward processing in patients with schizophrenia – relevance for negative symptoms

Chair: Stefan Kaiser, Geneva, Switzerland
Co-Chair: Florian Schlagenhauf, Charite, Berlin, Germany

  

Electrophysiological Correlates of Reward Dysfunctions and Negative Symptoms 
in Schizophrenia
Giulia Maria Giordano 
Naples, Italy                                   
Alterations in reward processing as biomarkers in schizophreniaMariia Kaliuzhna 
University Geneva, Genf
Altered belief updating in patients with schizophreniaFlorian Schlagenhauf 
Charité, Berlin
Negative symptoms, dopamine, and model-based and model-free decision making      Christian Sorg 
LMU Munich

 

S-3  Early detection and early intervention of bipolar disorders: New results

Chair: Andreas Bechdolf, Vivantes Klinikum am Urban und im Friedrichshain, Charité Universitätsmedizin, Berlin, Germany
Co-Chair: Sophie Parker, Youth Mental Health Research Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK 

Young People At Risk for Developing Bipolar Disorder: First Two-Year Findings from the Multicenter Prospective, Naturalistic Early-BipoLife StudyAndrea Pfennig
University of Dresden
Frequency and Predictors of Emerging Bipolar-Spectrum Disorders in Adolescents Hospitalized for Non-psychotic Mental Health Problems: Results from a Prospective StudyChristoph U. Correll
Charité, Berlin
The Long-Term Prospective Validity of Bipolar At-Risk Criteria in Clinically Help-Seeking Young PeopleAndreas Bechdolf, 
Vivantes Klinikum am Urban 
und im Friedrichshain and Charité, Berlin
A novel treatment for young people at high-risk of developing bipolar disorder using cognitive therapy: CBTBAR                                                                                                                                                                                                                                                                                                                                                    Sophie Parker
Youth Mental Health Research Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester

 

S-4 Effects of exercise interventions on clinical outcome and brain plasticity in schizophrenia

Chair: Peter Falkai, LMU, Munich, Germany
Co-Chair: Wiepke Cahn, University Utrecht, NL 

Effects of physical exercise on cognition and clinical symptoms of
schizophrenia: results from the multicentre ESPRIT study
Isabel Maurus
Department of Psychiatry 
and Psychotherapy, LMU Munich
Implementing exercise as a therapeutic strategy for schizophrenia.Wiepke Cahn
University Medical Center Utrecht
Physical exercise and brain plasticity in schizophreniaLukas Röll
Department of Psychiatry 
and Psychotherapy, LMU Munich
Combining aerobic exercise with clemastine to promote myelin plasticity                            Peter Falkai, 
LMU University Hospital, Munich

 

S-5  The motor dimension of psychosis

Chair: Sebastian Walther, Bern, Switzerland, and Würzburg, Germany
Co-Chair: Peter van Harten, Maastricht, NL

Neural correlates of psychomotor slowing and treatment options using 
transcranial magnetic stimulation
Sebastian Walther
Bern & Würzburg
Central role of motor areas for negative symptom factors in schizophrenia                         Katharina Stegmayer
Bern
Acute drug-induced movement disordersPeter van Harten
Maastricht

 

S-6  Promoting understanding of emerging psychosis: new findings on basic symptoms

Chair: Frauke Schultze-Lutter, Department of Psychiatry and Psychotherapy Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Germany
Co-Chair: Joachim Klosterkötter, Germany

The “substrate-closeness” of basic symptoms: a historical viewJoachim Klosterkötter
University Hospital Cologne
The biological correlations of visual basic symptomsRebecca Lencer
University Hospital Schleswig-Holstein Lübeck
The association of basic symptoms with personality characteristicsMarius Wrulich
University Hospital HHU, 
Düsseldorf
Basic symptoms in the community: results of the Bern Epidemiological At-Risk (BEAR) studyFrauke Schultze-Lutter
University Hospital, HHU, Düsseldorf

 

S-7  Dysfunctional brain connectivity and markers of inflammation in psychoses

Chair: Paola Bucci, University of Campania “Luigi Vanvitelli”, Naples, Italy
Co-Chair: Matthias Kirschner, Division of Adult Psychiatry, Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland

Cytokine levels as a predictor of social functioning in subjects with ultra-high risk for psychosis: A multicenter cohort studyTomiki Sumiyhoshi/ Yuji Yamada
Department of Preventive 
Intervention for Psychiatric Disorders, 
National Institute of Mental Health, 
National Center of Neurology 
and Psychiatry, Kodaira, Tokyo
Neuroimaging correlates of inflammation in subjects with first-episode schizophreniaGiulia Cattarinussi
Department of Psychological Medicine, 
Institute of Psychiatry, Psychology and Neuroscience, King’s College London, 
London
Illness-related variables and abnormalities of resting-state brain functional connectivity in schizophreniaGiulia Maria Giordano
University of Campania 
“Luigi Vanvitelli”, Naples
Connectome architecture shapes large-scale cortical alterations in schizophrenia: a worldwide ENIGMA studyMatthias Kirschner
Division of Adult Psychiatry, 
Department of Psychiatry, 
Geneva University Hospitals, Geneva

 

S-8  The Synaptic Hypothesis of Schizophrenia: A 21st Century Update

Chair: Ellis Chika Onwordi, Wolfson Institute of Population Health, Queen Mary University of London, UK
Co-Chair: Peter Falkai, LMU, Munich, Germany

Identifying candidate schizophrenia treatment targets from brain-enriched isoforms
of CACNA1C
Nicola Hall 
Department of Psychiatry, 
University of Oxford, UK
Modelling brain maturation to unveil the basis of synapse loss in schizophreniaCarl Sellgren 
Department of Physiology and 
Pharmacology, Karolinska Institute
Reduced synaptic density in schizophrenia: evidence from in vivo PET studiesEllis Chika Onwordi
Wolfson Institute of Population Health, 
Queen Mary University of London
Aerobic exercise enhances synaptic plasticity in schizophreniaPeter Falkai
LMU University Hospital, Munich

 

S-9  The art of prescribing clozapine: novel developments in the treatment with clozapine

Chair: Dan Cohen, MHO North-Holland North, NL
Co-Chair: Hein de Haas, Amsterdam, The Netherlands 

Treatment outcome in long-term clozapine treatmentDan Cohen
MHO North-Holland North
Substance use disorder in schizophrenia: a neglected therapeutic
effect of  clozapine
Hein de Haas
Arkin, Amsteram
An evidence-based proposal for the relaxation of the regulations 
for mandatory   leukocyte monitoring.  
P.F. J. Schulte
MHO North-Holland North
Does neutrophil fluorescence mark treatment adherence to clozapine?                        W.H. Man
Meander Medical Center, Amersfoort

 

S-11 CBT interventions for patients at-clinical high risk of psychosis, patients with early psychosis, and patients with acute delusions: results of pilot trials and randomized-controlled trials

Chair: Stephanie Mehl, Department of Psychiatry and Psychotherapy, Philipps-University of Marburg, Germany
Co-Chair: Andreas Bechdolf, Vivantes Klinikum am Urban und im Friedrichshain, Charité Universitätsmedizin, Berlin, Germany

Results of the Prevent-Study and prediction of transition to psychosis, 
psychopathology and social functioning
Henrik Müller
Department of Psychiatry and 
Psychotherapy, University of Cologne
Feasibility and Efficacy of an Acceptance and Mindfulness-Based Group
Intervention for Young People with Early Psychosis (Feel-Good-Group)                         
Andreas Bechdolf
Department of Psychiatry and 
Psychotherapy, Charité, Berlin
Efficacy of an emotion-oriented version of Cognitive Behavior Therapy
for patients with delusions (CBTd-E) in comparison to wait list 
in a single-blinded randomized-controlled trial
Stephanie Mehl
Department of Psychiatry and 
Psychotherapy, 
Philipps-University of Marburg

 

S-12  Unraveling Cerebellar Contributions to Symptoms in Schizophrenia: Insights into Pathophysiology and Therapeutic Circuit-Guided Targets

Chair: Indrit Bègue, Laboratory for Neuroimaging and Translational Psychiatry, Department of psychiatry, University of Geneva & University Hospitals of Geneva, Geneva, Switzerland
Co-Chair: Catherine Stoodley, Developing Brain Institute, Children’s National Hospital, Departments of Neurology and Pediatrics, George Washington School of Medicine and Health Sciences, Washington DC, USA

Cerebellar modulation of behavior, brain activation, and neural networks relevant to psychosis  Chatherine Stoodley
Developing Brain Institute Children’s 
National Hospital Departments of Neurology 
and Pediatrics 
George Washington School of Medicine and Health Sciences, Washington DC
Down to the nitty-gritty of ‘cognitive dysmetria: Precision mapping of cerebellar connectivity to cognition and psychopathology in psychosisHengyi Cao
Institute of Behavioral Science, 
Feinstein Institutes for Medical Research
Division of Psychiatry Research, 
Zucker Hillside Hospital New York
Dynamic connectivity patterns of the cerebellum and ventral tegmental area relate to negative symptoms of schizophrenia and are stable over timeIndrid Bègue
Laboratory for Neuroimaging and 
Translational Psychiatry 
Department of Psychiatry
University of Geneva 
& University Hospitals of Geneva
Therapeutic noninvasive neuromodulation of cerebellumMark A. Halko
Schizophrenia and Bipolar Disorder Research Program McLean Hospital, Belmont
Harvard Medical School, Boston

 

S-13  Early detection of depression: a life-course perspective

Chair: N. Wege, HHU Düsseldorf, Germany
Co-Chair: E. Greimel, KJPP LMU, Germany

„ich bin alles“: Information portal on depression and mental health 
in children and adolescents - a project aiming at improving depression
literacy, prevention and early intervention
Sara Kaubisch
LMU Hospital Munich
Prediction of deterioration of depressive symptom severity among 
older adults – results from the 1000BRAINS population-based studies
Julia Christl
University Hospital, HHU, Düsseldorf
Stressors that trigger the depressive episode from patients‘ perspectiveNatalia Wege
University Hospital, HHU, Düsseldorf
 
The influence of subclinical depressive symptoms on cognition 
and functional connectivity in old age
Pascal Grumbach
Research/Science Center Jülich  

 

S-14  Perceived Threat: Advances in Understanding Psychological, Physiological, Neurobiological and Molecular Factors of Paranoia

Chair: Katharina Stegmayer, University Hospital of Psychiatry and Psychotherapy, University of Bern, Switzerland
Co-Chair: Michal Hajdúk, Comenius University, Bratislava, Slovakia

The Role of Paranoia in the Perception of Social Interaction in 
Schizophrenia Spectrum Disorders – Behavioral and Psychophysiological Correlates
Michal Hajdúk
Comenius University in Bratislava
Safety Behaviours Maintain Paranoid Delusions in the Daily Life of Individuals with Psychotic Disorders: Evidence from an Ecological Momentary Assessment StudySven Schönig
Department of Clinical Psychology & Psychotherapy, University Hamburg
Altered interpersonal space in schizophrenia is associated with paranoia, altered stress regulation, and unfavourable outcomes in 6 months’ follow-upAdamantini Chatzipanagioti
University Hospital of Psychiatry and Psychotherapy, University of Bern
Paranoia is associated with markers of parvalbumin interneuron pathology and structural and functional alterations in the amygdala and ventral hippocampus in schizophreniaKatharina Stegmayer
University Hospital of Psychiatry and Psychotherapy, University of Bern 
 

 

S-16  Translation in Psychiatry: Early detection of psychosis, computer-assisted diagnostics and risk-adapted therapy: The CARE Project 

Chair: Eva Meisenzahl, Heinrich-Heine-University Düsseldorf, Germany
Co-Chair: Nikolaos Koutsouleris, Clinic of Psychiatry, University LMU, Munich, Germany

The challenge of translationEva Meisenzahl
University Hospital, HHU, Düsseldorf
Clinic of early detection in psychosisFrauke Schultze-Lutter 
University Hospital, HHU, Düsseldorf
Computer-based systems in CARENikolaos Koutsouleris
LMU University Hospital, Munich
 
Risk adapted therapy in HR psychosis                                                                                  Ursula Leyens
University Hospital, HHU, Düsseldorf

 

S-17 Gene-environment interactions in affective disorders and psychosis: results from imaging genetics, epigenetics and psychophysiology

Chair: Philipp Sämann, Neuroimaging Core Unit, Max Planck Institute of Psychiatry, Munich, Germany
Co-Chair: Sergi Papiol, Max Planck Institute of Psychiatry, Munich, Germany

Modulatory role of polygenic load on the beneficial effects of physical activity on hippocampus volumes in chronic schizophrenia patientsSergi Papiol
Max-Planck Institute of Psychiatry, Munich
Endophenotype potential of nucleus accumbens functional connectivity: 
effects of polygenic risk for schizophrenia interacting with childhood adversity
Philipp Sämann
Max-Planck Institute of Psychiatry, Munich
Epigenetic age acceleration: principle and correlations with psychiatric 
disease load and neurocognition
N. Yusupov
Max-Planck Institute of Psychiatry, Munich
Data-driven cognitive pupillometric response profiles and their polygenic
relationship to educational attainment
 J. Fietz
Max Planck Institute of Psychiatry

SO - Symposia (Oral Presentations)

SO-10

SO-10-O1:
Cornelius Ehlers, Alberta Health Services, Addiction and Mental Health, Red Deer, Alberta, Canada
Perceived Client Experiences of Participants supported by the Children and Adolescent Stabilization Team in Red Deer, Alberta

SO-10-O2: 
Marco Zierhut, Charité – Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Berlin, Germany
The effect of mindfulness-based group psychotherapy on biological and psychological stress parameters in schizophrenia spectrum disorders

SO-10-O3: 
Seval Bekiroğlu, Başkent University, Faculty of Health Sciences, Social Work Department, Ankara, Turkey
The Family Experiences of Individuals Diagnosed with Schizophrenia in Turkey: A Qualitative Study

SO-10-O4: 
Vladislav Yakimov, Department of Psychiatry and Psychotherapy, University Hospital LMU, Munich, Germany
Blood-cerebrospinal fluid barrier integrity is associated with dyslipidemia in schizophrenia-spectrum disorders

 

 

SO-15

SO-15-O1: 
Alp Üçok, Istanbul Faculty of Medicine, Department of Psychiatry, Istanbul, Turkey
Help-seeking from traditional healers in patients with severe mental illness

SO-15-O2: 
Daniela Mier, Department of Psychology, University of Konstanz, Germany
Perception of trust and sexually transmitted infections in schizophrenia patients 

SO-15-O3:
Jana von Trott, LMU Munich, Germany
Early Recognition and Prediction of Psychosis and other Mental Health Diseases 

SO-15-O4:
A. Khuntia, LMU Munich, Germany
BMI gap: a new tool to quantify obesity-related brain variation